Journal of Psychopharmacology
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on pre-clinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behaviour, and the mechanisms underlying these effects.
The Journal of Psychopharmacologyis truly international in scope and readership. This journal is a member of the Committee on Publication Ethics (COPE)
Impact Factor: 3.898
Ranking: Psychiatry (SCI) 32 out of 140 | Clinical Neurology 35 out of 192 | Pharmacology & Pharmacy 45 out of 255 | Neurosciences 70 out of 252 |
5-Year Impact Factor: 3.442
5-Year Ranking: Psychiatry (SCI) 43 out of 140 | Clinical Neurology 57 out of 192 | Pharmacology & Pharmacy 64 out of 255 | Neurosciences 108 out of 252
The Journal of Psychopharmacology is published monthly (12 times a year) by SAGE Publications (London).
The Journal of Psychopharmacology is available electronically on SAGE Journals Online
Annual Subscription (12 issues)
A subscription to Journal of Psychopharmacology is included in the membership benefits of BAP.
For subscription information please visit jop.sagepub.com or contact SAGE Publications Ltd email: firstname.lastname@example.org; website: www.sagepub.co.uk
- Print ISSN: 0269-8811
- Online ISSN: 1461-7285
The Journal of Psychopharmacology is abstracted / indexed in many databases. See a full list
Submission of manuscripts
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Journal of Psychopharmacology Editorial Office as follows:
Dr Pallab Seth
Journal of Psychopharmacology Editorial office
Imperial College London
Du Cane Rd
London, W12 0NN